Number of the records: 1  

Prevalence of Perfusion Defects Detected by Stress (99m)Technetium Sestamibi Myocardial Perfusion Single-photon Emission Computed Tomography in Asymptomatic Patients with Breast Cancer

  1. 1.
    0505361 - ÚI 2020 GR eng J - Journal Article
    Melichar, B. - Doležal, J. - Šrámek, V. - Kalábová, H. - Krcmová, L. - Hyšpler, R. - Studentová, H. - Vosmík, M. - Pecka, M. - Svobodník, A. - Pecen, Ladislav - Doležel, M. - Solichová, D.
    Prevalence of Perfusion Defects Detected by Stress (99m)Technetium Sestamibi Myocardial Perfusion Single-photon Emission Computed Tomography in Asymptomatic Patients with Breast Cancer.
    Anticancer Research. Roč. 34, č. 7 (2014), s. 3689-3694. ISSN 0250-7005. E-ISSN 1791-7530
    Keywords : long-term survivors * coronary-artery-disease * c-reactive protein * radiation-therapy * risk-factors * cardiovascular-disease * urinary neopterin * prognostic value * heart-disease * cardiac death * Atherosclerosis * breast cancer * single-photon emission computed tomography
    Impact factor: 1.826, year: 2014

    Aim: The aim of the present study was to investigate myocardial perfusion in relation to disease history and laboratory parameters of atherosclerosis risk in asymptomatic patients with breast carcinoma. Patients and Methods: One-hundred and eighty-one patients with breast carcinoma were studied. Myocardial perfusion was assessed using single-photon emission computed tomography (SPECT) with (99m)technetium sestamibi. Results: Perfusion defects were detected in 12 patients (7%). Higher body-mass index, increased concentrations of D-dimers, C-reactive protein, fibrinogen, glucose, triglycerides, and urinary albumin, a history of hypertension and of radiotherapy to the left chest wall were all associated with increased risk of perfusion defects. In a multivariate stepwise selection logistic regression model, body mass index, albuminuria and radiotherapy to the left hemithorax were significantly associated with the presence of perfusion defects. Conclusion: In addition to other factors, treatment history may be associated with the presence of perfusion defects in patients with breast cancer.
    Permanent Link: http://hdl.handle.net/11104/0296806

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.